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ABSTRACT 
 
 An optical biosensor for lactate detection is described. By encapsulating enzymes 
and phosphorescent oxygen sensing molecules within permeable hydrogel materials, a 
lactate-sensitive change in emission lifetimes was achieved. The relative amount of 
monomer was varied to compare the response of the enzyme-phosphor system in three 
homo- and co-polymer materials: poly(2-hydroxyethyl methacrylate) (pHEMA) and two 
copolymers of pHEMA and poly(acrylamide) (pAam). Diffusion analysis demonstrated 
the ability to control lactate transport by varying the hydrogel composition, while having 
a minimal effect on oxygen diffusion. Sensors displayed the desired dose-variable 
response to lactate challenges, highlighting the tunable, diffusion-controlled nature of 
the sensing platform. Short-term repeated exposure tests revealed enhanced stability for 
sensors comprising hydrogels with acrylamide additives; after an initial “break-in” 
period, signal retention was 100% for 15 repeated cycles. Evaluation of long-term sensor 
performance revealed significant reduction in lactate sensitivity for all materials 
investigated. Sensor response was quickly saturated in a low oxygen testing 
environment, indicating further work is needed to enhance viability of platform for 
implantation. Finally, because this study describes the modification of a previously 
developed glucose sensor for lactate analysis, it demonstrates the potential for mix-and-
match enzyme-phosphor-hydrogel sensing for use in future multi-analyte sensors. 
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CHAPTER I 
INTRODUCTION 
1.1 Overview 
Sensors capable of rapid analyte detection are essential for improving 
personalized healthcare
1
. Further, the ability to accurately detect and track substrate 
concentrations in vivo allows for precise diagnosis and better management of many 
chronic diseases
2
. Diabetes, one such disease, affects nearly 21 million people in the 
U.S. and 300 million people worldwide
3
. Diabetic patients suffer from abnormally high 
blood glucose levels, a consequence of the bodies’ inability to produce or respond 
appropriately to physiological levels of insulin. Therefore, patients must take daily 
injections in order to maintain normo-glycemia and encourage the cellular uptake of 
glucose, which otherwise would be toxic. Chronic hyperglycemia (high blood glucose) 
increases a patient’s risk to various pathologies including nephropathy, retinopathy, and 
neuropathy
2
.  Additionally, hypertension is almost twice as common in diabetics when 
compared to healthy patients
4
.  
Complications of hyperglycemia notwithstanding, acute-hypoglycemia can be 
problematic in its own right. Severe hypoglycemia can no doubt be fatal
5
, and has been 
linked to both cognitive impairment and nerve cell death
6
.  Three recent reports indicate 
that complications of hypoglycemia are responsible for 4%
7
, 7%
8
, and 10%
9
 of deaths of 
patients with type 1 diabetes. Expectedly, clinical studies report significantly improved 
long term prognoses for patients who maintain proper control of blood glucose levels 
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when compared to those who do not
10
. Thus, tight control of blood glucose is essential 
for proper diabetes management. 
Similarly, studies have shown L-lactate to be an important biomarker in many 
critical care
11
 and clinical
12
 applications. While lactate is a normal byproduct of cellular 
metabolism, intracellular concentrations of lactate increase more dramatically during 
anaerobic respiration. Interstitial lactate levels rise with anaerobia, leading to 
accumulation in muscles and other tissues. High concentrations of lactate are associated 
with muscle soreness, pain, and impaired function
13
. Therefore, lactate is useful in 
assessing a variety of acute deoxygenation events including hypovolemia (shock)
14
, 
heart disease
15
, and renal failure
16
. High lactate concentrations are also commonplace in 
traumatic injury, where a patient has undergone significant blood loss. In fact, 
monitoring of blood lactate is shown to improve identification of patients requiring 
resuscitative care (93%) when compared to standard blood pressure monitoring (67%) 
11
, 
highlighting it’s potential as an accurate metric for systemic health assessment in critical 
care situations. Nearly all soft tissue damage is correlated to an increase in lactate
17
. This 
makes continuous tracking useful for dynamic monitoring of active-duty military and 
other high risk personnel. Further, lactate tracking can be used to approximate tissue 
oxygenation in endurance athletes
18
, a parameter used to estimate muscle fatigue and 
overall fitness. Therefore a continuous lactate monitor may be used when optimal 
training intensities and minimal fatigue are desired. 
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1.2 Standard analyte monitoring techniques 
 Typically, lactate/glucose is analyzed by placing a small blood sample on a 
disposable electrode coated with a substrate-sensitive enzyme. The concept, originally 
developed by Clark et al
19
 to measure oxygen tension in cardiac surgery, is the basis for 
most commercially available glucometers. Glucometers rely on hydrogen peroxide 
(H2O2) produced from the catalysis of glucose and oxygen by glucose oxidase (GOx). If 
subjected to a baseline current, H2O2 will dissociate, inducing a change in charge 
directly proportional to glucose concentration.  
 It is suggested that diabetic patients check their blood glucose levels 4-5 times 
daily. Blood sampling requires painful fingersticks and may lead to patient 
noncompliance, causing many patients to check blood sugars less frequently. Lactate 
detection is equally painful and may lead to noncompliance. Lactate is infrequently used 
in critical care situations even though reports indicate it to be a highly reliable biomarker 
for emergency health assessment
11
.  
 Aside from being painful and inconvenient, ex vivo sampling does not provide 
caregivers or patients the ability to track systemic fluctuations over time, giving little 
insight into long term trends. The aforementioned facts necessitate the development of a 
continuous monitor, yet there remains a lack of effective techniques. 
1.3 Continuous analyte monitoring techniques 
 To date, there have been a number of attempts to develop miniaturized platforms 
for continuous monitoring of various biochemical metabolites, most notably glucose
20
. 
Contemporary continuous glucose monitoring (CGM) systems rely on GOx to produce 
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H2O2 at the surface of an implanted electrode and the resulting change in electric 
potential is then correlated to interstitial glucose concentrations
20a
. Typically, a polished 
needle type Au/Pt electrode is exposed to a solution of GOx, glutaraldehyde, and bovine 
serum albumin. Glutaraldehyde is known to crosslink enzymes at surface amine groups 
while maintaining an active enzyme conformation, allowing for physical adsorption of 
the enzyme onto the electrode without substantial loss of catalytic activity. Next, the 
enzyme-electrode is dip-coated in a biocompatible polymer to aide in tissue integration. 
Functionalized electrodes may contain thin-film coatings of various materials which 
function as glucose-diffusion barriers. Increasing coating thickness works to mitigate 
enzyme saturation and therefore extend glucose-sensitive range. The same concept has 
also been applied to lactate sensing using the lactate-sensitive enzyme lactate oxidase 
(LOx)
20b
.   
 Currently, a number of continuous glucose monitoring systems are commercially 
available, including Medtronic’s Guardian® Real Time System, Dexcom’s G4® 
Platinum System, and Abbott Laboratories FreeStyle™ Navigator II system. These 
FDA-approved devices are a major step forward when compared to ex vivo blood 
sampling. While enzyme electrodes and their various iterations have proven useful, the 
immune response elicited by the implant consistently leads to sensor failure. The entry 
wound caused by implantation initiates a chain of immune reactions beginning with 
inflammation, protein adsorption, and macrophage recruitment. Fibrotic encapsulation of 
the implanted sensor is the final defense against the foreign body. Encapsulation of the 
enzyme-electrode significantly alters analyte diffusion to the sensor surface, resulting in 
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a reduction in sensitivity. Figure 1.1 shows an illustration of the foreign body response 
to an implanted sensor and its effect on glucose diffusion. 
Figure 1.1. Illustration of foreign body response to implant 
 
 Aside from diffusion concerns, enzyme deactivation will also reduce sensitivity 
to glucose. H2O2 production is necessary to transmit an electrical signal across the skin. 
H2O2 is known to be a strong biochemical oxidizer as well as corrosive in high 
concentrations. H2O2 deactivates the immobilized GOx, leading to reduced production. 
The end result is similar to fibrotic encapsulation; a reduction in electric potential is 
observed at a given glucose concentration. Both of these transient effects require that 
CGM devices be recalibrated every few days. Current CGM devices are effective for 4-7 
days before bio-fouling effects render sensors useless. Further, the implantation site 
provides a potential bacterial pathway, leading to an increased risk of infection. 
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1.4 Optical techniques for analyte detection 
Optical techniques have been investigated for noninvasive estimation of analyte 
concentrations in vivo to avoid biocompatibility issues associated with electrochemical-
based sensing modalities. Optical methods display many advantages over amperometric 
detection. Optical systems rely on photon transfer and detection, eliminating need of a 
transcutaneous connection. Previous reports have shown the feasibility of using dual-
wavelength polarimetry
21
, optical coherence tomography
22
, and Raman spectroscopy
23
 
as methods to approximate various biochemistries in vivo. Malik et al demonstrated how 
rotation of plane polarized light in glucose containing solution can be used to estimate 
glucose levels. Vitreous humor was chosen as the testing medium, providing an easily 
accessible detection site. Further, utilization of dual-wavelength polarimetry reduced 
signal noise associated with corneal birefringence. Malik et al conducted live animal 
experiments, showing promise for in vivo glucose detection. Researchers at University of 
Texas Medical Branch and Texas A&M University demonstrated the use of optical 
coherence tomography and Raman spectroscopy as techniques for detection of either 
glucose or lactate. Esenaliev et al exploited glucose-dependent backscattering effects to 
estimate glucose concentration within tissues. Glucose is well known to reduce 
scattering coefficients of tissues
24
; changes in coherent backscattering were used to 
estimate concentrations in vivo, effectively creating a glucose-sensitive system. 
Alternatively, Caspers et al used Raman spectroscopy to provide spatially-resolved 
spectra of the fingertip. This study proved large variations in lactate concentration at the 
surface of the skin and 30 μm below.  All of these systems are sensitive to lactate- or 
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glucose-concentration-dependent changes in emitted/scattered light. Both glucose and 
lactate are small, meaning biochemical signatures attributed to each can be very low 
depending on the technique employed. Therefore, it can be difficult to reproduce 
consistent results in a clinical setting due to the small intrinsic signals from target 
molecules. As previously noted, light is scattered by tissue, meaning localized tissue 
heterogeneity may lead to erroneous estimation of in vivo concentrations. These 
techniques are intensity-based, making them susceptible to differences in temperature, 
pH and other physiological variables which may alter flux of emitted photons. 
1.5 Phosphorescent analyte detection 
To amplify optical signals above background and interference variability in a 
dynamic in vivo environment, implantable materials are being designed as “transducers” 
to convert chemical concentration into a phosphorescent signal. Recently, highly 
sensitive phosphors have been developed and applied for biomolecular assay 
applications
25
. These molecules absorb and emit at wavelengths within the commonly 
termed “optical window” (λ=650-1350 nm), allowing for photon transmission through 
skin
26
. Phosphors are characterized by relatively long emission lifetimes in the µs range, 
compared to tissue fluorophores with nanosecond decays, meaning it is possible to 
discriminate these signals from background and natural fluorescence using sophisticated 
optical analysis techniques. As with other optical systems, strong signal-to-noise ratios 
are important for accurate analyte detection, making phosphors attractive for 
subcutaneously implanted sensors. 
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While there are a multitude of commercially available dyes, those displaying 
oxygen sensitivity are most pertinent to this work. Previous studies by McShane et al 
made significant contributions to the development of biosensors based on O2-quenched 
metalloporphyrins. These reports describe glucose sensing platforms based on a number 
of ruthenium-and platinum-porphyrin conjugates
27
. To fabricate a glucose sensor, 
metalloporphyrin conjugates were co-immobilized along with GOx in various diffusion-
limiting matrices. As glucose diffuses inward, oxygen is consumed by GOx. These dyes 
respond to O2 reduction by emitting at higher phosphorescent lifetimes and intensities. 
Thus, by altering materials used to entrap the proposed sensing molecules, diffusion-
controlled response over a wide range of glucose concentrations was realized
27a, 28
. 
While this platform has shown promise for glucose sensing, it’s efficacy in sensing other 
metabolites has not been established. 
1.6 Research objective  
The goal of this thesis is to demonstrate the effectiveness of a sensing platform 
developed by McShane et al for alternative analyte detection, in this case L-lactate. 
Work described herein builds upon previous glucose sensing modalities
27-28
. A long 
emission lifetime benzoporphyrin was co-localized along with a lactate selective enzyme 
(LOx) within various homo- and co-polymer hydrogels to demonstrate diffusion-
controlled, lactate-sensitive response over a wide range of physiologically relevant 
concentrations.  
 Freshly prepared lactate sensors were characterized by a number of commonly 
known sensor metrics. To investigate diffusion-controlled nature of the platform, bulk 
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lactate- and oxygen-transport properties were assessed. A relationship between diffusion 
coefficients and macro-sensor response is proposed, inferring material-dependent lactate 
sensitivity. Next, acute- and long-term sensor stability was evaluated in various dynamic 
storage conditions to assess suitability of materials for immobilization of sensing 
chemistry. Afterwards, sensors were evaluated in a low O2 environment to better 
understand in vivo performance capabilities.  
 Finally, this works illustrates the general applicability of the enzyme-
benzoporphyrin-hydrogel platform for alternative analyte analysis. While initially 
purposed for glucose detection, substitution of a discrete, lactate-specific enzyme within 
diffusion-tailored hydrogels shows the device’s potential as a multi-analyte sensing 
platform. 
1.7 Chapter organization 
This thesis is organized as follows:  
Background is sectioned into three parts. The first section includes theory and 
applications for enzymatic-based sensing modalities as well as recent advances that 
explore the utilization of lactate-selective enzymes for optical detection of lactate. Next, 
long emission lifetime metalloporphyrin complexes relevant to the given application are 
discussed, with attention given to the theory of phosphorescent emission lifetime and 
porphyrin sensitivity to oxygen quenching. Afterwards, a review of hydrogel 
biocompatibly is given, specifically those materials used by previous groups for enzyme 
immobilization. Finally, theory to quantitatively describe molecular transport through 
materials is presented.  
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Studies of previous diffusion-controlled sensing modalities developed by 
McShane and others are reviewed to better understand overall approach. A brief 
discussion will help to understand how these past studies relate to the material presented 
here. 
Materials and Methods presents all relevant precursor materials needed to 
produce sensors as well as comprehensive synthesis techniques. A bench-top testing 
apparatus is described, with special attention given to flow cell design. Instrumentation 
used to interrogate sensors, relevant sampling techniques, and methods to evaluate 
optical response at ambient and low O2 conditions are described. Sensor performance is 
evaluated by determining analytical range, sensitivity, total change in lifetime, and 
response time. Additionally, techniques to assess lactate and O2 transport through each 
material are presented. Finally, a description is given of two experimental setups 
designed to test acute- and long-term sensor stability.  
Results and Discussion presents studies’ findings and includes discussion of 
possible implications. First, design of a flow cell used in sensor evaluation is presented 
along with a description of fabrication techniques. Next, lactate and oxygen diffusion 
profiles of each material are presented and discussed. Optical response to step increases 
in bulk lactate are presented and evaluated. Variability in homo- and co-material 
diffusivity is compared to optical response to highlight the tunable nature of the 
platform. Analysis of acute- and long-term stability is done to evaluate suitability of 
materials for immobilization of proposed sensing chemistry.  
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Conclusions and Future Work details closing remarks on sensor viability and 
efficacy as an implantable device. Preliminary results on sensor response within a low 
oxygen environment evaluate possible in vivo capabilities. Implications of these results 
are discussed in relation to sensor response at ambient oxygen. Conjecture on potential 
methods to accurately tune sensor response at low oxygen as well as techniques to 
improve enzyme stability are discussed. Finally, general applicability of sensor platform 
for sensing of multiple substrates and future applications are presented. 
References include reports by previous groups which help to understand the 
presented work. 
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CHAPTER II 
BACKGROUND AND SIGNIFICANCE 
2.1 Enzymatic sensing techniques  
2.1.1 Theory 
In the field of medical diagnostics, a sensing platform capable of real-time in 
vivo analyte tracking has been sought after for decades. Recently, there have been a 
number of attempts to develop miniaturized platforms for continuous monitoring of 
various biochemical metabolites
20
.  Many of these devices rely on an electrochemical 
sensing assay for metabolite detection. Typically, an oxidoreductase enzyme catalyzes 
oxygen along with another substrate. Equation 2.1 describes kinetics of an 
oxidoreductase enzyme in the presence of substrate and O2. 
 
     
  
       
  
        
       
  
    
   
  
          
Equation 2.1. Kinetics of generic oxidoreductase 
 
where Eox and Ered are  the oxidized and reduced form of  enzyme E, S  is  the substrate, 
P is a byproduct, EredX1 is the reduced enzyme-substrate complex, E
*
ox X2 is the oxidized 
enzyme-substrate complex, and k1, k2, k3, k4  are the reaction rate constants. For 
electrochemical-based methods (e.g. contemporary continuous glucose monitors), H2O2 
production is assumed to be the direct result of the electro-reduction/oxidation of the 
substrate S. H2O2 readily oxidizes metal, making it possible to measure electric potential 
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across a subcutaneously implanted electrode. Similar approaches have been investigated 
for lactate sensing
29
. As is the case with GOx and glucose, lactate/O2 catalysis is 
possible with the oxidoreductase enzyme lactate oxidase (LOx). LOx catalyzes the 
reduction of molecular O2 by lactate. Kinetics of LOx are described by equation 2.2. 
 
           
  
       
  
               
       
  
    
   
  
          
Equation 2.2. Kinetics of lactate oxidase 
 
where Eox and Ered are the oxidized and reduced form of LOx, EredX1 is the LOx-lactate 
complex, E
*
ox X2 is the LOx-O2 complex, and k1, k2, k3, k4 are the reaction rate constants. 
While electrochemical lactate sensors rely solely on H2O2 production, optical devices 
can detect either H2O2 production or O2 consumption. Thus, production or consumption 
of either chemical can be used to transmit an optical signal. 
 2.1.2 Recent advances 
 A number of enzyme-based sensing modalities for amperometric detection of 
lactate have been reported
20b, 29b
. Thomas developed a contact lens functionalized to 
detect lactate in vitreous humor. Poly(ethylene terepthalate) wafers were cut to size and 
thoroughly cleaned. Next, a Clark-type Pt electrode was lithographically patterned onto 
the wafer surface. A solution containing LOx, glutaraldehyde, and bovine serum 
albumin was mixed and deposited onto the surface of the electrode-wafer. Finally, 
functionalized wafers were dip-coated in polyurethane (PU) and dried overnight. 
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Exposure to lactate produced a measureable current, thus displaying sensitivity. 
Although the device required a physical connection to a receiver, the authors promised 
the integration of wireless transmission to be described in future studies. Only then 
would it be effective for everyday use. 
Other groups have successfully used optical techniques to detect lactate
20b, 30
. 
Marquette et al were able to couple LOx and a peroxide sensitive fluorophore, luminol, 
to the end of an optical fiber bundle
31
. Upon exposure to lactate, sensors demonstrated 
an increase in fluorescent intensity due to H2O2 oxidation of the co-localized luminol. 
This technique provided high sensitivity, although a narrow analytical range (30 pmol). 
In other studies, Hu et al developed highly fluorescent cupric oxide nano-particles 
functionalized with terephthalic acid, a substrate in peroxidase catalysis. Nano-particles 
displayed enzyme mimetic characteristics, albeit with more stable activity than seen in 
natural peroxidase
29c
. By coupling this H2O2-sensitive system with LOx, a lactate 
specific fluorescent nano-sensor was developed. Both of these methods displayed narrow 
lactate detection ranges, much lower than the typical 0-2 mMol lactate of healthy human 
serum.  
 Alternatively, Trettnak et al developed a lactate sensor by monitoring oxygen 
consumption as a function of lactate concentration. This was accomplished by co-
localizing LOx and an O2-sensitive fluorophore, decacyclene 
32
. LOx and solubilized 
decacyclene were covalently bound to nylon 6-6 membranes which were then attached 
to a fiber optic bundle. Upon lactate exposure, sensors emitted high fluorescent 
intensities due to the decrease in available oxygen and subsequent decrease in 
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fluorescent quenching. Dremel et al described a similar O2-sensitive modality for 
detection of L-lactic acid in food products
33
. With proper preconditioning of fluorescent 
sensing chemistry, continuous lactate analysis was possible for ≥2 days.  
These reports show the possibility of optical lactate detection, yet in vivo 
capabilities were hardly considered. Again, intensity-based measurements are 
susceptible to physiological changes in pH, temperature, and subcutaneous environment, 
making sensors unreliable if tissue heterogeneity exists near the implantation site. 
Therefore, alternative techniques should be explored in order to develop a more robust 
sensing mechanism. 
2.2 Long lifetime metalloporphyrins  
 2.2.1 Theory 
To reduce signal variability seen in intensity-based measurements, emission 
lifetime can be used as a means to sensitively interrogate implants. Emission lifetime is 
defined as the average time a molecule will stay in its excited state after photon 
absorption. Upon excitation, electrons in the highest occupied orbital are excited to the 
lowest unoccupied orbital and beyond. After some time, electrons “relax” to a ground 
state, in the process emitting photons of different wavelengths. Re-emission is not 
instantaneous due to various radiative and non-radiative transitions. Fluorescent lifetime 
is defined as the average time a molecule takes to return to ground after excitation to a 
singlet energy state. This transient reduction in intensity can be measured as voltage 
decay across a detector. Using equation 2.3, a decay curve can be approximated. 
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Equation 2.3. 1
st
 order decay 
 
where [X]0 and [X]t  are the concentrations of excited molecules initially and at time t, 
respectively, and   is the decay rate. Emission lifetime, τ, is defined as the inverse of  . 
Lifetime is an intrinsic property and thus does not depend on the method of 
measurement. It is also a state function, independent of excitation wavelength and 
duration of light exposure. Additionally, lifetime measurements are mostly independent 
of intensity measurements
34
 within a range of fluorophore concentrations. 
 As mentioned previously, there are number of internal non-radiative processes 
which can cause a delay in photon emission. Vibrational relaxation is the simplest of 
these transitions. After photon absorption, a molecule rapidly relaxes to the lowest 
vibrational state within its current excited energy level; this is observed as a change in 
intra- or inter-molecular kinetic energy. It is also possible for an excited electron to 
transition from a vibrational energy level in one energy state to another vibrational level 
in a lower energy state. Unlike vibrational relaxation, internal conversion involves a 
change in electronic state and is more likely to occur if there is significant overlap 
between vibrational and electronic energy levels. An additional non-radiative transition 
(and perhaps most important to this work) is intersystem crossing. This is the slowest of 
the transitions shown in the Jablonski diagram in figure 2.1. Intersystem crossing is a 
transition from one electronic state to another with a different spin multiplicity. In a 
singlet state, an excited electron is paired with a ground state electron of opposite spin. 
Intersystem crossing occurs when an excited electron undergoes spin reversal. This 
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triplet state is considered a “forbidden transition” and typically occurs less frequently. 
The radiative emission between an excited triplet state and ground state is commonly 
referred to as phosphorescence. The timescale of phosphorescent decay is typically 
much longer than fluorescent decay. Certain phosphors are characterized by 
exceptionally long lifetime decays in the μs-ms range35.  
Figure 2.1. Jablonski diagram 
 
 Some phosphors are sensitive to quenching by molecular O2. If O2 concentrations 
are high, energy absorbed from a photon is transferred through O2 molecules to an 
electronic ground state rather than being re-emitted as another photon. Thus, 
phosphorescent intensity and emission lifetime profiles can be related to oxygen 
concentration. This is described by the Stern-Volmer relationship. 
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Equation 2.4. Stern-Volmer relationship of fluorescence/phosphorescence 
 
where τ0 and I0 are phosphorescent lifetime and intensity in absence of O2, τ and I are 
lifetime and intensity, Ksv is the phosphor specific Stern-Volmer constant, and [O2] is 
oxygen concentration.  
2.2.2 Recent advances 
A number of groups have conjugated porphyrin compounds with various metal 
atoms to produce dyes with exceptionally long phosphorescent lifetimes
25a, 25c, 35-36
. 
O’Riordan et al developed a series of Pd(II)- Pt(II)-co-proporphyrin I derivatives for in 
vitro labeling of various antibodies
25a
. Activity and stability analyses were performed on 
antibody-dye conjugates as well as on unlabeled antibodies. Similarly, O’Sullivan et al 
described a method of tagging oligonucleotides with Pt(II) co-proporpyhrins
25c
. 
Purification via HPLC and absorption spectra of compounds were done to characterize 
the developed probes. As is the case with most fluorescent imaging probes, high 
emissions must be maintained to ensure accurate time-resolved measurements. 
Therefore, Na2SO3 was added as a deoxygenator to reduce molecular O2 quenching 
effects.  
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While sensitivity to oxygen may be problematic for protein binding applications, 
it is useful in sensor development. Niedermair et al developed a number of O2-sensitive 
near infrared Pt(II)- Pd(II)-benzoporphyrins
35a
 which displayed peak excitations within 
the commonly termed “optical window” (λ=650-1350 nm); wavelengths with low 
absorption in hemoglobin (UV) and water (IR). Auto-fluorescence of tissue is relatively 
low and scattering effects are deemed the most important light-tissue interaction, 
allowing for rapid penetration through the skin. This makes the developed dyes attractive 
for subcutaneously implanted sensors. The benzoporphyrin used in this study is a 
derivative of a phosphor developed by Niedermair et al. Palladium (II)-
tetramethacrylate-benzoporphyrin (BMAP) was donated by Soya Gamsey of PROFUSA 
(PROFUSA, San Francisco, CA, Patent WO 1998003512 A1). BMAP structure and 
emission spectra are shown in figure 2.2.  
(a) 
 Figure 2.2. (a) Structure of BMAP (b) emission spectra of BMAP at 633 nm 
excitation 
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(b) 
Figure 2.2., Continued (a) Structure of BMAP (b) emission spectra of BMAP at 633 
nm excitation 
 
 A covalently bound central Pd atom acts as an oxygen binding center, similar to 
the Fe atom found in hemoglobin. In ambient conditions, emission intensities remain 
low due to de-excitation via energy transfer to O2 by collisional quenching; this means 
that incident photon energies are non-radiatively transferred through O2 to ground state 
rather than being emitted as phosphorescence. BMAP displays excellent storage stability 
in powder or solution form. Absorption spectrum was determined using 1 H NMR (300 
Mhz, CDCl3). Spectral analysis was done at room temperature and ambient O2. 
Excitation at λ = 633 nm gave λpeak = 805 nm emission, indicating a large Stokes shift 
and the possibility of deep tissue penetration for in vivo analyte analysis. 
In this work, BMAP and LOx were co-localized to create a lactate-selective 
sensor. As previously noted, LOx activity is a function of lactate and oxygen 
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concentration. As lactate levels are increased, more oxygen is consumed. BMAP is 
highly sensitive to oxygen quenching, meaning localized oxygen concentrations can be 
estimated by phosphorescent intensity and emission lifetime profiles. Therefore, 
estimation of lactate concentration is possible by monitoring the O2 quenching kinetics 
of BMAP in an enzyme-controlled O2 micro-environment. 
LOx and BMAP comprise the proposed sensing chemistry, yet alone they do 
little to account for the development of a functional sensor. LOx is quickly saturated at 
lactate concentrations found in vivo. Likewise, the effective optical signal is also 
saturated at low lactate levels. Further, co-localization of sensing chemistry is needed in 
order to prevent leaching. These facts highlight the need for a suitable immobilization 
matrix to limit diffusion and realize a functional sensor. 
2.3 Hydrogel materials  
 2.3.1 Theory 
Hydrogels may be used to entrap and control substrate diffusion to the 
aforementioned sensing molecules. Small molecule transport depends on a material’s 
molecular weight, cross-link density, swelling profile in water, and polymer-molecule 
interaction
37
. To evaluate a diffusion coefficient, DL, Fick’s 2
nd
 law of diffusion is used. 
 
  
  
   
   
   
 
Equation 2.5. Fick’s 2nd law of diffusion 
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where c is concentration of substrate in the hydrogel, DL is the diffusion coefficient, and 
x is distance. This partial differential equation models diffusion as a function of substrate 
concentration in bulk solution. 
 O2 transport can be assessed indirectly via evaluation of Stern-Volmer quenching 
kinetics of an O2-sensitive phosphor immobilized within the hydrogel. It is assumed that 
phosphor entrapped within a hydrogel will display different quenching properties than 
free phosphor, thus indicating a change in oxygen availability. If Ksv values determined 
for immobilized phosphors differ from those found in free solution, material-dependent 
profiles can be determined. Comparison of Ksv values may be used to assess relative 
oxygen permeability of selected materials. 
2.3.2 Recent advances 
 To functionalize sensing chemistry into a useful biosensor, immobilization 
within a bioinert matrix is necessary. Hydrogels have been used extensively for in vivo 
applications due to their low toxicity and bio-fouling properties
37
. Hydrogels typically 
display high swelling ratios, with some able to take on 99% of their weight in water. 
Degradation of polymer matrix is highly dependent on repeat unit linkage. Some ester-
linked polymers (such as poly(lactic-co-glycolic acid)) degrade rapidly while others 
display resistance to linkage-hydrolysis
38
. Degradable materials are attractive for 
controlled-drug release applications
39
, however can be difficult for enzyme-based 
biosensors. If materials degrade quickly, frequent recalibrations are required to account 
for changes in small molecule transport, limiting their long term functionality. Therefore 
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it is necessary to employ mechanically robust and biointert polymers for enzyme-based 
applications. 
Two materials, poly(2-hydroxyethyl methacrylate) (pHEMA) and 
poly(acrylamide) (pAam) are synthetic polymers used in numerous biomedical devices. 
pHEMA has been widely used in soft contact lenses
40
, drug delivery systems
41
, and 
tissue engineering constructs
42
. pHEMA is attractive due to its low cytotoxicity and 
biofouling properties
43. pHEMA’s ability to swell in water without losing mechanical 
integrity makes it an ideal material for in vivo applications
44
.  
Similarly, poly(acrylamide) (pAam) has many uses, initially purposed as a 
separation medium in gel electrophoresis
45. Like pHEMA, pAam’s hydrophilic nature 
and low biofouling properties make it suitable for in vivo applications
46
. Further, both 
pHEMA and pAam have been investigated for immobilization of enzymes and other 
indicator molecules in a number of biosensors
27a, 28
. Previous work has reported that 
crosslinking enzymes within these hydrogels can enhance catalytic stability
47
. Thus, 
homogenous distribution of sensing chemistry within a biocompatible gel is attractive 
for enzyme based sensing applications.  
2.4 Current trends in optically active, enzyme-based hydrogel materials for analyte 
detection 
Recently, a number of groups have reported on the development of hydrogel-
based enzymatic phosphorescent biosensors
27-28, 48
. One approach developed by 
McShane and Brown et al used calcium alginate gel microspheres as a medium for a 
phosphorescent glucose sensing chemistry
48b
. Microspheres were prepared following a 
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procedure modified from Wan et al
49
. Briefly, a solution of 3 wt. % sodium alginate and 
50 mg GOx was added to iso-octane to create water-in-oil emulsion droplets. After 
mixing at 5000 rpm for 10 minutes in an overhead stirrer, 10 wt. % calcium chloride 
solution was pipetted into the emulsion to slowly crosslink alginate. Afterwards, 
microspheres were rinsed and suspended in distilled water. Microsphere-enzyme 
conjugates were then exposed to a buffer solution (pH=12) containing an O2-sensitive 
phosphor, ruthenium (II) tris(4,7- diphenyl-1,10-phenanthroline). Electrostatic coupling 
of the cationic phosphor and the anionic microspheres allowed for precipitation of dye 
into the alginate matrix. Afterwards, alternately charged polyelectrolyte nano-films were 
assembled onto microspheres. Previous studies report on highly accurate nano-film 
deposition onto colloidal surfaces
50
. This deposition technique allows for precise control 
over sensor diffusion properties, thereby allowing for control over sensor response to 
bulk glucose.  
 Microspheres were interrogated by glucose challenges using a bench-top flow 
through system. Incoming glucose and oxygen was consumed by GOx, and optical 
response was transmitted as a change in phosphorescent intensity of the immobilized 
phosphor. Sensors responded linearly up to 140 mg/dL glucose, yet coverage of the 
entire physiological range was not achieved due to high glucose diffusion. Enzymatic 
production of H2O2 led to GOx deactivation. Additionally, photobleaching was a major 
concern, and required extensive correction when processing data. 
Another approach developed by McShane and Stein et al incorporated a similar 
sensing chemistry into functionalized microcapsules
48a
. This approach used calcium 
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carbonate microparticles as sacrificial templates for the fabrication of hollow 
polyelectrolyte microcapsules. Initially, GOx and horseradish peroxidase (HRP) were 
added to a CaCl2 concentrated aqueous solution. HRP is a peroxidase which catalyzes 
H2O2 into water and O2. By co-immobilizing HRP alongside GOx, it was possible to 
eliminate H2O2 from the system, thereby enhancing GOx stability. Next, Na2CO3 was 
rapidly added to the mixture to induce crystallization of CaCO3 microparticles. Bi-
enzyme loaded particles were rinsed and re-suspended in buffer solution. Afterwards, 
microparticles were subjected to polyelectrolyte nano-film deposition as described 
previously. Following adsorption of polyelectrolyte films onto the surface of particles, 
ethylenediaminetetraacetic acid (EDTA) was added to dissolve calcium core, thereby 
creating a hollow capsule containing both GOx and HRP. 
SEM images were taken of particles in the absence of enzymes, co-precipitated 
particles, and the resulting microcapsules. Intra-capsule enzyme concentration was 
determined using both fluorescence analysis and a Bradford protein assay. Additionally, 
enzyme release profiles were investigated to determine stability of sensing modality. 
Recently, McShane’s group has immobilized a phosphorescent glucose sensing 
chemistry within various bioinert hydrogel matrices
27a, 28
. Generally, 2-hydroxyethyl 
methacrylate (HEMA) has been used as the primary monomer for enzyme-dye 
immobilization. Roberts et al polymerized GOx and catalase alongside Palladium (II) 
meso-tetra(4-carboxyphenyl) porphine (PdP) in a pHEMA matrix. Similar to HRP, 
catalase catalyzes H2O2 into water and O2, effectively enhancing sensor stability. 
Initially, an aqueous solution containing GOx or GOx/catalase and a dimethyl sulfoxide 
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(DMSO) solution containing PdP are made and set aside. Separately, a polymer 
precursor solution containing HEMA, ethylene glycol, and tetraethylene glycol 
dimethacrylate (TEGDA) was made and vortexed.  Ethylene glycol acts as a co-solvent, 
while TEGDA was used to crosslink the monomer. Immediately prior to 
photopolymerization, 2,2-dimethoxy-2- phenyl-acetophenone (photoinitiator) was added 
to precursor solution. Finally, GOx/catalase and PdP solutions were combined and 
gently mixed. Precursor solution was pipetted into a premade mold and polymerized 
under UV light. Afterwards, GOx was crosslinked using 1- ethyl-3-(3-
dimethylaminopropyl)carbodiimide hydrochloride and N-hydroxysuccinimide.  
Sensors were tested for glucose sensitivity using the bench-top testing system 
mentioned previously. Results indicated a largely linear response up to 225 mg/dL 
glucose for GOx-only sensors. Addition of catalase resulted in decreased sensitivity and 
a corresponding increase in analytical range (0-311 mg/dL glucose), thus enhancing 
sensor stability while maintaining adequate sensitivity in the physiological relevant 
glucose range. This work is promising, however long term stability and repeatability 
were not discussed.  
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CHAPTER III 
MATERIALS AND METHODS 
3.1 Materials 
Catalase, ethylene glycol, 2,2-dimethoxy-2-phenyl-acetophenone (DMAP),1-
Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC),  and sodium 
lactate were purchased from Sigma-Aldrich®
 
(St. Louis, MO). Dimethyl sulfoxide 
(DMSO) was purchased from VWR®
 
(Radnor, PA). Sodium chloride, potassium 
phosphate (dibasic), and potassium chloride were purchased from VWR® (Radnor, PA). 
Sodium phosphate (monobasic) was purchased from ACROS Organics™ (ThermoFisher 
Scientific Inc®, Waltham, MA). 2-hydroxyethyl methacrylate (HEMA) and 
tetra(ethylene glycol) methacrylate (TEGDMA) were purchased from Polysciences 
Inc™ (Warrington, PA).   Lactate oxidase from Aerococcus viridians (LOx), acrylamide 
(Aam), and sulfo-N-hydroxysuccinimide (sulfo-NHS) were purchased from A.G. 
Scientific™ (San Diego, CA), AMRESCO® (Solon, OH), and G Biosciences™ (St. 
Louis, MO) respectively. Palladium (II) tetramethacrylated benzoporphyrin (BMAP) 
was donated by PROFUSA Inc., (San Francisco, CA). All chemicals were reagent grade 
and used without further purification. 
3.2 Sensor preparation 
 To synthesize gels, 2.5 mg DMAP was weighed into a micro-centrifuge tube. 
67.2 v/v% concentration of Aam was dissolved in DMSO separately. 250 µL monomer 
precursor (containing the proper v/v% ratio of HEMA to Aam solution plus 5 µL 
TEGDMA) was added to DMAP and vortexed. Next, 90 µL ethylene glycol was added 
 28 
 
as a co-solvent and vortexed again. 50 µL of 10 mM BMAP solution in DMSO was 
added along with 125 µL LOx/catalase solution (pH=7.4) in a 10:1 molar ratio. Both dye 
and enzyme solutions underwent repeated pipetting to ensure proper mixing. Sensors 
were made with three different co-polymer materials: 75:25 pHEMA:pAam, 90:10 
pHEMA:pAam and pure pHEMA. Resulting solutions were pipetted into a premade 
mold (consisting of a 0.03” spacer sandwiched between two clean microscope slides) 
and polymerized under UV light. Gel slabs were removed from molds and placed into a 
15 mg sulfo-NHS and 6.6 mg EDC buffered solution. Enzyme cross-linking was done 
overnight at 4 C˚. After thorough rinsing, sensors were stored in fresh PBS at 4 °C in 
foil-covered centrifuge tubes to limit photobleaching of BMAP. 5 mm sensor strips were 
cut and rinsed prior to testing. 
3.3 Bench-top testing system 
 A custom flow-through system was used to validate in vitro sensor response. 
Two positive displacement VICI® M6 liquid pumps (Valco Instruments™ Inc., 
Houston, TX) are connected to reservoirs containing either a highly concentrated (20 
mM lactate) solution or phosphate buffered solution (PBS) (0 mM lactate). A 
LabVIEW™ program controls flow rates from both pumps independently. Flow from 
reservoirs is mixed prior to reaching a specially designed flow cell in which four sensors 
are immobilized. In a typical experiment, three lactate sensors and a pHEMA-BMAP 
oxygen sensor were placed in the flow cell for simultaneous monitoring. Lactate 
concentrations were increased every hour to ensure stable responses were achieved. 
Solution is flowed at a rate of 4 mL/min through the system. Discrete lactate challenges, 
 29 
 
coined as “flight plans”, consist of progressively higher concentrations ran in series 
before a return to baseline. A schematic of the experimental setup is shown in figure 3.1. 
Custom flow cells were fabricated to secure sensors during experimentation; advantages 
and limitations of designs are discussed in section 4.1. All testing was performed at 37 
C˚. 
Figure 3.1. Illustration of flow through system (adapted from Andrus et al, 2015)
51
 
 
 Sensors were interrogated using a custom optical instrument. This instrument 
uses a Lumileds Luxeon Rebel red LED excitation source (Phillips®, Amsterdam, NL). 
The LED has peak intensity at λtyp=627 nm and a bandwidth of ≈25 nm, giving it a 
relatively narrow emission spectra. A wide (125˚) viewing angle, as is seen here, is 
common among most LEDs. LED is rated to 700 mA and operated at 200 mA. Emission 
spectrum was confirmed spectroscopically with a peak at λ=633 nm. A FF01-631/36 
excitation filter (Semrock™, Rochester, NY) is used to ensure proper emission 
bandwidth. Upon phosphor excitation, emitted photons are collected with a ball lens 
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situated at 8mm distance from the LED port; this light is collimated and passed through 
a FF02-809/81 emission filter (Semrock™ ) prior to detection with a Si PMT (SensL™, 
Cork, IR). The filter’s bandwidth is nearly equal to BMAP emission spectra, ensuring 
likelihood of strong SNR. The entire system is contained within a miniaturized 1.5” 
diameter plastic casing; each such “reader head” interrogates a single sensor of interest. 
A LabVIEW™ program controls LED intensity, pulse on/off parameters, data 
acquisition, and emission lifetime calculation from the measured decays as described 
below. 
3.4 Data analysis 
 Emission lifetimes were obtained by monitoring voltage decay across the Si 
PMT. Peak intensity was measured immediately following a 500 μs LED pulse. 
Sampling of voltage was delayed for 7 μs to reduce interference from the LED excitation 
pulse. Background voltage was calculated as the average intensity of the last 20% of the 
decay duration (2500 μs). Emission lifetime decay curves were found by averaging 128-
256 acquired intensity decay profiles. Acquisitions between t = 507 μs and t = 2500 μs 
were repeated quickly, generally taking 1.3 seconds per cycle. Collected data were fit to 
the exponential in equation 2.3 using a nonlinear least squares Levenberg-Marquardt 
algorithm. Parameter bounds of the exponential fit limit long lifetime intensities to 0-3 
V. From these averaged exponential decays lifetime, τ, and long lifetime intensity are 
found. 
 A number of commonly used performance metrics were used to assess sensor 
response. After exposing sensors to an initial lactate challenge, adjustments were made 
 31 
 
to modulate sensors within a more appropriate range. Specifically, adjustments to lactate 
concentrations were done to collect many points within the sensitive range; this allows 
creation of reliable calibration curves. Focus was given to four performance 
characteristics: sensitivity, analytical range, change in lifetime, and response time. 
Sensitivity is found as the linear slope of each calibration curve. Analytical range is the 
span over which sensitivity is maintained, defined as the interval between upper and 
lower limits of detection (LODhigh/LODlow). Emission lifetimes at 0 mg/dL lactate plus 
(+) 3σ are used to calculate LODlow. Similarly, LODhigh is found from emission at 
enzyme saturation minus (-) 3σ. Change in emission lifetime is calculated as the entire 
range of τ between 0 mg/dL and sensor saturation. Response time refers to lag between 
lactate input and steady sensor response. Response time is found by averaging temporal 
differences between τ-3σ and τ+3σ of the previous step for the initial three steps of each 
flight plan. Analytical range, sensitivity, change in lifetime, and response time were 
calculated for n=3 sensors and metrics are reported as average ±95% CI.  
3.5 Diffusion analysis 
 A horizontal diffusion cell system was used to assess lactate transport in sensor 
materials following procedures detailed in previous work
28
. Briefly, sensors were 
prepared as described in section 3.2, except that materials were polymerized in a 0.01” 
glass mold; the thinner samples allowed for more rapid experimentation. Sensors were 
preconditioned in a 60 C˚ water bath for 10 days in order to completely deact ivate 
immobilized LOx. A lactate flight plan was monitored prior to diffusion experiments to 
verify enzyme deactivation. Deactivation of LOx mitigates lactate consumption concerns 
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and ensures reliable analysis of diffusion kinetics. A schematic of the experimental setup 
is shown in figure 3.2. 
Figure 3.2. Illustration of diffusion cell setup 
 
 7-mm sensor punches were sandwiched between two 7 mL reservoirs. Feeder 
reservoirs contain 1 M lactate solution, while permeate reservoirs contain PBS solution. 
100 µL samples were taken from each reservoir and replaced with fresh PBS over 
several hours. Samples were analyzed with a 2700 Select Biochemistry Analyzer (YSI 
Inc
™
, Yellow Springs, OH). Rates of change, dc/dt, were found by plotting lactate 
concentrations in permeate reservoirs over time; dc/dt was estimated as the slope of a 
linear fit to these data. To calculate a diffusion coefficient, DL, Fick’s 2
nd
 law of 
diffusion was used, with the assumption that clac(0)= at t(0) in the permeate reservoir 
and homogenous mixing in each, 
 
   
  
  
 
  
 
  
Equation 3.1. Solution of Fick’s 2nd law for diffusion coefficient 
1 M lactate 0 M lactate 
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where DL is the diffusion coefficient of lactate in cm
2
/s, dc/dt is change in permeate 
reservoir concentration over time,   is thickness of gel, V is the ratio of volume of 
reservoir to area of gel exposed to solution, and ф is the partition coefficient. Ф is 
assumed to be 1 in every calculation, meaning relative DL values are reported. Although 
not absolute values, the calculated DL values provide insight into relative changes in 
diffusion; these are deemed appropriate for the purposes of this study.  n=3 sensors were 
tested at 25 C
˚
 and DL is reported as an average. 
 Quenching profiles of immobilized BMAP were analyzed to assess O2 transport 
in sensor materials. Compressed air and N2 gas were bubbled into 1 L PBS to evacuate 
O2 prior to reaching a flow cell containing n=3 sensors plus a pHEMA-BMAP oxygen 
reference.  A 1179A mass flow controller and a pressure gauge, model PR 4000F (MKS 
Instruments™, Andover, MA) control N2 and compressed air flow out of submerged 
bubbler probe and dissolved O2 is externally verified with an O2 microsensor 
(UniSense™, Aarhus, DK). Oxygen was decreased in a stepwise manner at 
concentrations of 210 µm, 105 µm, 52.5 µm, and 21 µm. After, flow cells were loaded 
with 8M glucose and 30 μM GOx solutions to consume any remaining oxygen. Flow 
cells were sealed and emissions were monitored overnight, allowing for detection of τ0. 
A value for Ksv, described by the Stern-Volmer relationship detailed in equation 2.4, is 
defined as the linear fit of τ0/τ vs. [O2]. n=3 sensors were tested at 37 C
˚
 and Ksv is 
reported as an average. A schematic of the experimental setup is shown in figure 3.3. 
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Figure 3.3. Illustration of oxygen testing system 
 
3.6 Acute stability 
 Sensors were subjected to 20 consecutive lactate challenges to evaluate acute 
signal retention. Lactate challenges were adjusted to normalize enzymatic consumption 
rates within each material, meaning flight plans were determined based on the unique 
upper limits of detection (LODhigh). Flight plans range between 0 mg/dL and the 
predetermined LODhigh of each sensor material. “Flight plans” were run in series, with a 
return to baseline between each cycle. Afterwards, signal loss was calculated as percent 
change in emission lifetime from the initial (cycle 1) flight plan. Percent change was 
calculated at LODhigh as well as at intermediate concentrations. n=3 sensors plus a 
pHEMA-BMAP oxygen reference were tested at 37 C
˚
 and signal retention is reported as 
an average. 
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3.7 Long-term stability 
 Sensors were interrogated by periodic lactate challenges over 4 weeks to evaluate 
long term signal retention.  On day 0, sensors (3 formulations, n=3 for each formulation, 
2 sets, 18 sensors total) underwent flight plans ranging between 0 mg/dL-LODhigh. 
Sensors were stored at 37 C˚ in either PBS or 8 mg/dL lactate solution. PBS-stored 
samples were stored in 50 mL centrifuge tubes within a separate incubator. Lactate-
exposed sensors were stored in a flow cell connected to an 8 mg/dL lactate reservoir 
under low flow conditions (1 mL/min); this accounts for lactate consumption and helps 
to maintain sensors in a steady lactate-concentrated environment. Thus, lactate-
consumption concerns were mitigated, allowing for more rigorous experimentation. 
After 14 days and 28 days of storage, identical flight plans were administered. 
Afterwards, signal retention was calculated as seen in section 3.6; percent signal change 
was calculated as the difference in emission lifetimes at day 28 and day 0. Signal 
retention was calculated at LODhigh as well as at intermediate concentrations.  
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CHAPTER IV 
RESULTS AND DISCUSSION 
 
4.1 Flow cell fabrication 
A flow cell testing apparatus was designed and fabricated to evaluate sensor 
performance in vitro, Flow cells developed by past students interfaced with various 
lifetime measurement systems, yet none had been designed to work with the current 
instrument. Earlier flow cell iterations were typically made out of opaque materials with 
small windows to interrogate sensors, making it difficult to evaluate air bubble 
entrapment within the flow chamber. The proposed flow cell must transport lactate 
concentrated solution to the sensors while holding them in place. Further, flow cell 
material must mitigate light scattering effects to accurately assess sensor response. Thus, 
an optically clear flow cell which interfaces with the current bench-top system is needed.  
To fabricate a flow cell, 7/16” thick optically clear cast acrylic (McMaster Carr, 
Elmhurst, IL) was used. From the acrylic two 8” x 3” rectangles were cut out using a 
table saw. An 11 mL flow chamber was milled into one of the acrylic pieces to define 
the path liquid takes through the cell. Initially, 3 wells were cut into the bottom of the 
chamber and distributed evenly along its axis. Later iterations contained 4 wells to 
include an additional oxygen sensor for baseline measurements. An o-ring groove was 
milled around the edge of the flow chamber to properly seal the cell. The superficial 
surface of the top piece contains two ports which deposit and retrieve liquid from the 
flow chamber, allowing for connection to the liquid pumping system. The inferior 
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surface boasts a 0.1” thick wall which seals along the inside surface of the flow chamber. 
Through holes for #10-32 metal screws were cut around the exterior edge of the flow 
cell. Drawings as well as an exploded view of the new flow cell design are shown in 
figure 4.1. 
 
 
 
(a) 
Figure 4.1. (a) Exploded view (b) & (c) drawings of top and bottom pieces 
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(b) 
(c) 
Figure 4.1., Continued (a) Exploded view (b) & (c) drawings of top and bottom pieces 
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Flow cell allows for quick experimental setup, permitting a high throughput 
testing environment. Designs were pre-programmed into CNC software; fabrication 
typically takes between 2-3 hours. After every lactate challenge, sensors are removed 
and flow cell is washed with ethanol and distilled water. O-rings, metal screws, and 
inlet/outlet ports are replaced periodically and flow cells are stored together when not in 
use. 
4.2 Diffusion analysis 
 Figure 4.2a contains the measured permeate chamber lactate concentration for 
the three sensor types. Qualitatively, the increase in lactate transport through gels 
containing acrylamide is obvious. The calculated relative DL values for 75:25 
pHEMA:pAam, 90:10 pHEMA:pAam, and pure pHEMA are 5.7±0.3*10
-7 
cm
2
/s, 
4.0±1.0*10
-7 
cm
2
/s, and 3.1±1.6*10
-7 
cm
2
/s, respectively. 90:10 pHEMA:pAam sensors 
display a small increase in lactate transport when compared to pure pHEMA, suggesting 
more pAam is needed in order to substantially effect swelling properties. For 75:25 
pHEMA:pAam sensors, a ≈2 fold increase in lactate diffusion is seen relative to pHEMA 
sensors.  
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(a) 
(b) 
Figure 4.2. (a) Change of [lactate] in permeate chamber over time for three sensor types 
(b) Stern-Volmer plots for the same sensor types. Each set is an average of n=3 
compositionally identical sensors; errors bars denote 95% confidence intervals (adapted 
from Andrus et al, 2015)
51b, 52
 
 
 Figure 4.2b contains τ0/τ vs. [O2] plots for each material tested. Ksv values for 
75:25 pHEMA:pAam, 90:10 pHEMA:pAam, and pure pHEMA are 0.29±0.003 (% O2)
-1
, 
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0.28±0.010 (% O2)
-1
, and 0.28±0.002 (% O2)
-1
, respectively. These Ksv values match well 
with previous studies on similar materials
53
. Only the pure pHEMA and 75:25 
formulations were statistically different at the 95% confidence level; this difference, 
while statistically significant, is only a matter of 3.6% increase in oxygen quenching. 
Thus, the effects on oxygen diffusion are minimal. This is not surprising, as O2 is a very 
small, hydrophobic molecule with low solubility in water. Thus, transport may depend 
less on material cross-link density and more on the O2 favorability of each material. It is 
most important to appreciate here that the changes in polymer formulation dramatically 
change lactate diffusion while minimally altering oxygen diffusion. Thus, this particular 
combination of polymers allows tuning of lactate diffusion almost completely 
independently from oxygen. 
4.3 Sensor response 
To determine characteristic sensor response, lactate challenges were 
administered. Figure 4.3a contains a representative real-time “flight plan” plot of the 
change in phosphorescent lifetime for three 75:25 pHEMA:pAam sensors to 
progressively higher lactate concentrations. The observed stepwise response is common 
to all formulations, regardless of composition. Most sensors matched well with others 
from the same batch, while a few cases (such as Channel 2 in Figure 3a) were 
significantly different in their response to intermediate lactate concentrations. All lactate 
sensors plateau at a maximum lifetime between 225 and 250 µs. A fourth trace 
represents the response of the oxygen sensor placed in the same channel, indicating the 
stable oxygen level observed in the steady state even during lactate challenges.   
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(a) 
(b) 
Figure 4.3. (a) 75:25 pHEMA:pAam lifetime response to lactate interrogation (b) 
calibration curves for three sensor types. Each calibration curve contains points 
representing the average phosphorescent lifetime; error bars denote the 95% confidence 
intervals for n=3 sensors (adapted from Andrus et al, 2015)
51b, 54
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Figure 4.3b shows calibration curves representing the steady-state response to 
lactate for sensors based on the three different hydrogel types. Several points can be 
made from these data. First, all of the formulations yield the same lifetime at zero 
lactate, again reinforcing that the oxygen diffusion properties are essentially the same for 
each case. It is also immediately apparent that the incorporation of 25% acrylamide 
dramatically shifts the sensor behavior from the other two cases. First, the sensitivity to 
lower lactate levels was increased, while the lactate concentration at which lifetime nears 
the maximum (LODhigh) was cut in approximately half. Furthermore, the amount of 
variability between sensors increased significantly, as indicated by the larger confidence 
intervals. This increased variability is primarily a result of batch heterogeneity, which 
was observed visually in preparing the hydrogels.  The increased acrylamide content 
resulted in an obvious increase in gel phase separation/heterogeneity. Thus, sensors cut 
from the same initial hydrogel slab are more inconsistent in appearance. This apparent 
difference likely results in the changes in performance, which we attribute to variability 
in localized enzyme concentration and diffusion properties in the acrylamide-containing 
gels. This heterogeneity is less pronounced for the 90:10 copolymers. 
 Corresponding sensor figures of merit and diffusion metrics for the 75:25 
pHEMA:pAam, 90:10 pHEMA:pAam, and pure pHEMA materials are reported in Table 
1. These numbers quantitatively support the notion that increasing pAam precursor ratios 
are correlated to a decrease in range and a corresponding increase in sensitivity. This 
inverse relationship is explained by the properties of the two polymers. pAam is known 
to be significantly more hydrophilic than pHEMA due to polar amide groups present in 
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pAam’s primary structure. In fact, pAam is able to take on ≈80% its weight in aqueous 
solution (compared to ≈37% for pHEMA)55. Higher concentrations of pAam lead to a 
more loosely cross-linked matrix, and therefore a more rapid diffusion profile, as is 
clearly seen from the measured relative lactate diffusion values. In contrast, however, 
previous reports cited a much larger increase of diffusion when comparing pAam to 
pHEMA; diffusion of small molecules has been shown to be several orders of magnitude 
higher in pAam when compared to pure pHEMA
28
. Thus, the copolymer system retains a 
strong influence of the pHEMA even with 25% pAam.  
 This change in diffusivity alters kinetics of immobilized LOx and the resulting 
oxygen consumption profiles. Increased swelling allows local lactate and O2 molecules 
to interact more readily with LOx active sites, encouraging rapid enzyme saturation. As 
more O2 is consumed, BMAP is quenched less and therefore emits with a longer average 
lifetime. Thus, the optical saturation is reached at lower bulk lactate concentrations. 
Higher pAam concentration increases enzyme-substrate contact, effectively lowering 
usable range of the device. 
 An interesting note is that DL values scale well with sensitivity metrics. Addition 
of only 10% pAam does little to increase lactate diffusion (and therefore sensitivity). 
pAam is much more hydrophilic than pHEMA, but is needed in higher ratios to 
significantly affect gel micro-structure. Both sensitivity and DL metrics for the 75:25 
pHEMA:pAam sensor are double what is seen in pure pHEMA gels, indicating promise 
for high measurement precision within a normal lactate range. 
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 Total change in lifetime, Δτ, was similar for materials tested. Sensors all started 
with similar baseline τ; this means Δτ is mostly dependent on τ at enzyme saturation. A 
small statistical difference between pure pHEMA and 75:25 pHEMA:pAam sensors is 
seen, ≈4 µs; Δτ for 90:10 pHEMA gels overlap with the other two materials. 
 Calculated response time is not statistically different between the materials. All 
materials were able to achieve a stable optical response within a 20-minute window after 
introducing the step change in lactate level. This is similar to response times for current 
electrochemical-based sensors and is considered adequate to effectively monitor 
fluctuations in systemic conditions. 
 
Table 1. Compiled sensor metrics, values are average of n=3 sensors ± 95% confidence 
intervals (adapted from Andrus et al, 2015)
51b, 56
 
 
 
 
Monomers 75:25 
pHEMA:pAam 
90:10 
pHEMA:pAam 
Pure pHEMA 
Sensitivity [μs*dL/mg] 20.0±2.3 9.2±1.5 8.5±2.2 
Range [mg/dL] 1.1-12.7 0.7-35.0 0.4-38.2 
Δτ [μs] 203.9±1.5 204.6±4.3 212.0±4.0 
Response time [min] 19.0±2.9 16.4±1.7 15.2±1.2 
DL [cm
2
/s]*10
-7
 5.7±0.3 4.0±0.9 3.1±1.6 
τ0 [μs] 251.8±5.1 259.9±8.9 290.0±7.3 
Ksv [%
-1 
O2]*10
-2
 29.4±0.3 28.0±1.2 27.7±0.2 
Signal retention @ LODhigh [%]    
after 20 cycles 73.11±14.9 81.0±10.6 69.9±4.9 
4 weeks, PBS storage 18.4±4.0 63.3±10.2 59.7±10.7 
4 weeks, lactate storage 3.6 ±3.9 7.0±3.7 3.3±2.1 
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4.4 Acute stability 
 To evaluate acute signal reduction in response to lactate, sensors were exposed to 
20 consecutive lactate challenges. Lifetime values at 5, 10, and 20 lactate challenges 
were compared against initial flight plan lifetimes for freshly prepared sensors. Signal 
retention was calculated as a metric of the change in τ after repeated lactate flight plans. 
The relative difference of τ at cycle (flight plan) 20 to τ at cycle 1 is described in 
equation 4.1. 
 
                      
                       
                   
      
Equation 4.1. Signal retention calculation 
 
where τcycle x20 is the emission lifetime at cycle 20, τcycle x1 is lifetime for same 
concentration on the initial cycle, and τcycle 01 is the baseline τ recorded at 0 mg/dl lactate 
on cycle 1.  
Figure 4.4a contains representative data from the 90:10 pHEMA:pAam materials, 
indicating how the measured τ values at each lactate concentration changed over 20 
cycles. Figure 4.4b is a summary of the signal retention over 20 cycles for all three 
sensor types. For 75:25 pHEMA:Aam sensors, signal retention of 78.1±9.0%, 
76.1±18.4%, 73.1±14.9% is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. 
For 90:10 pHEMA:pAam sensors, signal retention of 85.5±20.8%, 80.6±16.5%, 
81.0±10.6% is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. Finally, for 
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pure pHEMA sensors, signal retention of 34.9±11.8%. 56.1±8.0%, 69.9±4.9%, is seen at 
1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. 
(a) 
Figure 4.4. (a) 90:10 pHEMA:pAam signal retention over 20 cycles (b) % retention of 
first cycle signal (c) % retention of fifth cycle signal, Markers indicate average values, 
and error bars represent 95% confidence intervals between measured signal retention for 
n=3 sensors (adapted from Andrus et al, 2015)
51b, 57
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(b) 
(c) 
Figure 4.4., Continued (a) 90:10 pHEMA:pAam signal retention over 20 cycles (b) % 
retention of first cycle signal (c) % retention of fifth cycle signal, Markers indicate 
average values, and error bars represent 95% confidence intervals between measured 
signal retention for n=3 sensors (adapted from Andrus et al, 2015)
51b, 57
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 Investigation of acute signal loss reveals an initial reduction in emission lifetime 
before a pseudo-stable response is reached, as there is no statistical change in τ after the 
5
th
 exposure cycle (Figure 4.4a). This “break-in” could be due to leaching of LOx not 
covalently bound to the hydrogel. A protein leaching study was performed on freshly-
prepared sensors using a colorimetric enzyme assay. n=3 sensors were stirred in 1 mL DI 
water, and results indicates no active enzyme present in solution above 10 ng/mL (data 
not shown). It should be noted that this leaching study indicates no loss of active enzyme 
and does not account for loss of denatured LOx. Nonetheless, chemical and mechanical 
stresses induced on enzyme during polymerization and swelling during equilibration are 
likely culprits for the apparent loss in sensitivity. Partially unstable protein moieties 
quickly denature within first lactate flight plan, leaving remaining LOx to function 
properly. Figure 4.4c shows signal retention at LODhigh between cycles 5-20. After an 
initial loss in activity, pAam-containing materials maintained a stable response, with no 
statistical difference from the 5
th
 cycle response to the 20
th
 cycle at any of the tested 
lactate concentrations. 
 These data suggest a positive relationship between sensor stability and increasing 
pAam concentration. Both 75:25 pHEMA:pAam and 90:10 pHEMA:pAam materials 
experienced statistically similar signal retention throughout the study, while pure 
pHEMA formulations displayed higher levels of LOx activity loss (about 50-70% 
retention between cycles 5-20). It follows that gels containing some acrylamide are 
better suited for retaining LOx activity, most likely due to the hydrophilic nature of 
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pAam that yields an encapsulation more consistent with the enzymes’ native 
environment.  
 Aside from leaching, chemical and mechanical denaturation issues, none of 
which were observed in our studies, enzyme activity is the primary issue for sensor 
stability. It is difficult to quantify enzyme activity within a semisolid medium. 
Furthermore, it is important to appreciate that, upon hydrogel immobilization, the 
kinetics of LOx no longer exclusively depend on lactate concentration. The LOx-
polymer interface restricts transport, making substrate less available as when in solution. 
This means that the hydrogel microstructure will directly affect the rate of lactate 
delivery to the enzyme; this system requires normalizing conditions for direct 
comparison. Since each material has a different calculated LODhigh, we chose to expose 
sensors to normalized concentrations relative to this upper limit during the experiment; 
this resulted in different absolute bulk lactate concentrations but effectively the same 
lactate flux. Although LODhigh was used in an attempt to normalize data, we recognize 
that dissimilar lactate challenges may provide for variable concentrations of substrate 
near immobilized LOx and therefore different reaction rates.  
4.5  Long-term stability 
 Figure 4.5a is a summary of the signal retention over 2 weeks for all three sensor 
types. For 75:25 pHEMA:Aam sensors stored in PBS, signal retention of 96.0±35.3%, 
78.6±17.0%, 82.8±6.1% is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. 
For 75:25 pHEMA:Aam sensors stored in lactate, signal retention of 10.9±12.0%, 
6.6±4.5%, 6.3 ±3.7%  is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. For 
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90:10 pHEMA:pAam sensors stored in PBS, signal retention of 71.0±26.7%, 
67.6±17.1%, 83.3±5.8% is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. 
For 90:10 pHEMA:pAam sensors stored in lactate, signal retention of 11.2±6.3%, 
10.7±1.0%, 19.5±1.0% is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. 
For pure pHEMA sensors stored in PBS, signal retention of 82.8±41.4%, 99.7±8.0%, 
97.9±1.0% is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. For pure 
pHEMA sensors stored in lactate, signal retention of 8.7±5.7%, 11.4±1.7%, 24.0±2.6% 
is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. 
 Figure 4.5b is a summary of the signal retention over 4 weeks for all three sensor 
types. For 75:25 pHEMA:Aam sensors stored in PBS, signal retention of 52.3±13.0%, 
22.7±5.9%, 18.4±4.0% is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. 
For 75:25 pHEMA:Aam sensors stored in lactate, signal retention of 8.8±10.1%, 
4.8±5.9%, 3.6 ±3.9%  is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. For 
90:10 pHEMA:pAam sensors stored in PBS, signal retention of 25.8±8.2%, 45.0±12.7%, 
63.3±10.2% is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. For 90:10 
pHEMA:pAam sensors stored in lactate, signal retention of 20.0±12.6%, 7.6±4.8%, 
7.0±3.7% is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. For pure 
pHEMA sensors stored in PBS, signal retention of 25.4±4.5%, 42.7±13.5%, 59.7±10.7% 
is seen at 1/3 LODhigh, 2/3 LODhigh, and LODhigh, respectively. For pure pHEMA sensors 
stored in lactate, signal retention of 1.8±4.2%, 2.1±2.0%, 3.3±2.1% is seen at 1/3 
LODhigh, 2/3 LODhigh, and LODhigh, respectively.  
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(a) 
(b)  
Figure 4.5. (a) % signal retention after 2 weeks (b) signal retention after 4 weeks, 
Markers indicate average values, and error bars represent 95% confidence intervals 
between measured signal retention for n=3 sensors 
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 PBS-stored sensors typically retain sensitivity better than sensors stored in 8 
mg/dL lactate, although signal loss is still significant throughout. At high lactate 
concentrations, both 90:10 pHEMA:pAam and pure pHEMA sensors stored in PBS 
maintain sensitivity better than 75:25 pHEMA:pAam. This is surprising, since acute 
degradation studies suggest materials with higher pAam content to be more suitable for 
enzyme immobilization. It follows that short term signal retention is higher in pAam-
containing gels, although over 2 and 4 weeks the largely pHEMA gels perform better, 
indicating LOx immobilized in the pure pHEMA and 90:10 pHEMA:pAam materials 
resists thermal deactivation better than LOx immobilized in the more loosely cross-
linked 75:25 pHEMA:pAam matrix. Similar signal retention is observed between pure 
pHEMA and 90:10 pHEMA:pAam materials, while 75:25 pHEMA:pAam materials 
display a significantly different signal retention profile, again suggesting that 
incorporation of only 10% pAam does little to affect sensor response.  
 While PBS-stored sensors exhibit some signal change after 4 weeks of storage, 
lactate-stored sensors display minimal sensitivity after 2 weeks. Week 2 and 4 lactate-
storage data indicates significant deactivation, suggesting poor stability under 
physiological-like conditions. An interesting note is that signal retention trends with 
pHEMA content for lactate-stored sensors at LODhigh. This may be explained by the 
relative lactate flux through each material. pAam-containing sensors display higher DL 
values, thus storage in 8 mg/dL lactate solution may result in increased catalytic activity 
when compared to pure pHEMA sensors. Increased catalysis may lead to more rapid 
enzyme deactivation, thus decreasing sensor stability. 
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 Data suggests sensors may resist thermal deactivation (from PBS-storage 
results), yet high temperatures coupled with a catalytically active environment (lactate-
storage) yields substantial signal loss.  Although 8 mg/dL lactate is within the 
physiologically relevant range of concentrations, it may be a worst case scenario. In 
future studies, lower lactate concentrations should be considered. 
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CHAPTER V 
CONCLUSIONS AND FUTURE WORK 
 
5.1 Sensor characterization 
In vitro characterization of a novel biosensor designed for lactate detection has 
been described. As far as we know, this study presents an implantable, phosphorescent 
lactate sensor never-before-seen in previous literature. An enzyme-oxygen, phosphor 
sensing chemistry was immobilized within three different co-polymer formulations, 
allowing for tunable macro sensor characteristics by controlling substrate diffusion 
through careful co-polymer selection. To demonstrate the diffusion-controlled nature of 
this platform, bulk transport properties of both lactate and oxygen were assessed; results 
indicate a positive relationship between diffusivity and sensitivity. This matched 
expectations based on known hydrophilicity differences between the pHEMA and pAam 
materials studied, though the magnitude of the gains in oxygen diffusivity were 
surprisingly low. Furthermore, this tuning in response properties was possible by 
adjusting lactate diffusion with minimal effect on oxygen diffusion and phosphor 
sensitivity to oxygen. 
While the hydrogel composition effects transport properties, there was also an 
apparent change in acute stability that favors the incorporation of at least some 
acrylamide. Interestingly, sensor stability to repeated lactate challenges does not directly 
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correlate with the diffusion properties studied herein. Results from 2 and 4 week stability 
evaluation indicate substantial loss of lactate sensitivity for all materials tested.  
5.2  Low O2 testing 
 5.2.1  Low O2 testing setup 
 It is well known that oxygen concentrations in subcutaneous tissue are 
significantly lower than ambient concentrations
58
. Therefore, sensors were interrogated 
by lactate challenges at low oxygen to accurately assess in vivo capabilities. To evacuate 
oxygen, a Systec
® 
Prep/Semi-Prep Scale degassing chamber (Biotech AB, Onsala, SE) 
and a Systec
® 
ZHCR
®
 vacuum pump were incorporated into the current bench-top 
testing system (figure 3.1). Degasser-vacuum pump combination is installed in-line 
between the VICI liquid pumps and the flow cell. Solution is flowed through the 
degassing chamber, thus removing dissolved gas prior to sensor exposure. Initially, 
sensors were subjected to pure PBS and ambient oxygen for 1 hour. Next, the vacuum 
pump was turned on and ran for 2 hours prior to lactate challenge, allowing for sensor 
stabilization at low oxygen. Afterwards, lactate challenges were administered as 
described in section 3.3, albeit at lower lactate concentrations. A microcontroller 
configured to the pump maintained vacuum pressure at 80 mmHg. Sensors were 
subjected to each lactate concentration for 1 hour at a flow rate of 4 mL/min and 
phosphorescent lifetimes were monitored using the BEACON instrument. Data analysis 
was performed following procedure outlined in section 3.4. All lactate challenges were 
performed at 37 C˚. 
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 5.2.2  Low O2 testing results 
 To determine characteristic sensor response at low oxygen, lactate challenges 
were administered. Figure 5.1a contains a representative real-time lactate flight plan of 
n=3 pure pHEMA sensors. Figure 5.1b contains lactate calibration curves at low oxygen 
for all materials. Figure 5.1c contains these calibrations juxtaposed against calibrations 
of same sensors at ambient oxygen. 
 
 
 
 
 
 
 
(a) 
Figure 5.1. (a) Pure pHEMA lifetime response to lactate interrogation at low oxygen (b) 
calibration curves for three sensor types at low oxygen. Each calibration curve contains 
points representing the average phosphorescent lifetime; error bars denote the 95% 
confidence intervals for n=3 sensors (c) calibration curves for three sensor types at low 
oxygen and ambient oxygen 
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(b) 
(c) 
Figure 5.1., Continued (a) Pure pHEMA lifetime response to lactate interrogation at 
low oxygen (b) calibration curves for three sensor types at low oxygen. Each calibration 
curve contains points representing the average phosphorescent lifetime; error bars denote 
the 95% confidence intervals for n=3 sensors (c) calibration curves for three sensor types 
at low oxygen and ambient oxygen 
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 Corresponding sensor performance metrics at low O2 for the 75:25 
pHEMA:pAam, 90:10 pHEMA:pAam, and pure pHEMA materials are reported in Table 
2. Low oxygen testing revealed a decrease in analytical range for all materials tested; 
analytical range is reduced (≈3.5x reduction for 75:25 pHEMA:pAam sensors, ≈9x 
reduction for 90:10 pHEMA:pAam sensors, and ≈11x reduction for pure pHEMA 
sensors) when compared sensor response at ambient oxygen. 80 mmHg vacuum pressure 
on the testing system at 0 mg/dL lactate results in baseline lifetimes τ≈100 µs for 90:10 
pHEMA:pAam and pure pHEMA materials; this matches well with baseline lifetimes 
observed in vivo for similar pHEMA-BMAP oxygen sensors (data not shown). However, 
baseline lifetimes (0 mg/dL lactate) for 75:25 pHEMA:pAam sensors are τ≈75 µs, 
indicating addition of pAam may allow higher levels of available oxygen in these 
materials. These short baseline lifetimes indicate pAam-containing materials may 
possess higher Δτ (and thus broader lactate sensitivity at low oxygen), although 75:25 
pHEMA:pAam sensors display rapid saturation upon lactate exposure as is seen in pure 
pHEMA sensors. Data suggests pAam may increase oxygen permeability, yet the 
increase in lactate transport through pAam-containing gels ultimately leads to rapid 
saturation.  
Table 2. Compiled sensor metrics at low O2, values are average of n=3 sensors ± 95% 
confidence intervals 
Monomers 75:25 
pHEMA:pAam 
90:10 
pHEMA:pAam 
Pure pHEMA 
Sensitivity [μs*dL/mg] 47.1±4.7 46.1±3.5 42.6±1.1 
Range [mg/dL] 0.3-3.4 0.5-3.9 0.6-3.5 
Δτ [μs] 156.6±11.0 151.2±5.0 152.6±4.0 
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5.3 Limitations and future work 
 5.3.1 Low O2 
Analytical range is significantly reduced during low oxygen testing; these results 
indicate oxygen availability may be the limiting factor in vivo. It is therefore likely that 
alternate materials with better oxygen transport may be better suited for long-term 
functionality. One potential solution is to further decrease lactate diffusion. Lower DL 
values correspond to less lactate/oxygen consumption, which could provide sensitivity 
over a broader range. This approach may require the use of materials other than pHEMA 
and pAam. Although other hydrogel materials may further restrict of lactate transport, 
they may also decrease oxygen permeability; this would be counter-productive, as data 
indicates oxygen availability to be a limiting factor. An ideal material would encourage 
oxygen transport while exhibiting DL values similar to sensors tested here.  
Results indicate further work is needed to develop sensors with adequate 
sensitivity at low oxygen. Certain siloxane-containing monomers are characterized by 
high oxygen permeability. Immobilization in such materials would increase oxygen 
availability to sensing chemistry. In theory, improved in vivo functionality may be 
achieved if pore size can be tuned to adequately restrict lactate transport.  
Another approach is to decrease LOx concentration in current and future sensor 
iterations. Reduction of LOx decreases local oxygen consumption, potentially providing 
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sensitivity at higher bulk lactate concentrations. An intensive panel containing siloxane-
based materials with varying concentrations of immobilized enzyme is likely needed to 
fabricate a sensor with appropriate sensitivity in vivo. 
 5.3.2 Sensor stability 
Sensors studied here display signal loss in both acute- and long-term studies, 
indicated by enzyme deactivation; this suggests enzyme-modification techniques may be 
applied prior to immobilization to enhance catalytic stability. Work by Ritter et al details 
glycosylation site-targeted attachment of poly(ethylene glycol) (PEG) chains to GOx. 
PEG-GOx displays higher resistance to deactivation when compared to native GOx
59
. 
Similarly, unpublished work by our group indicates electrostatic attachment of 
poly(ethylenimine) (PEI) to GOx improves thermal and operational stability. While 
these studies primarily focus on GOx modification, they could, in principle, also be 
applied to LOx. 
 5.3.3 Fabrication repeatability 
Sensors cut from the same gel display slightly different response profiles. 
Increasing pAam content seems to exacerbate batch-to-batch variability. This could be 
due to heterogeneity seen in pAam-containing gels; a result of disparate co-solvents 
(DMSO for Aam, aqueous buffer for LOx-catalase). Phase separation pre-
polymerization may be indicative of heterogeneous distribution of sensing chemistry. 
Repeatability is essential and variable enzyme concentrations between sensors may lead 
to disparate sensitivities. Clearly, work is needed to determine extent of phase separation 
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and subsequent enzyme aggregation. An enzyme modification technique that alters 
surface hydrophilicity as well as stabilizes catalytic activity would be ideal. Modified 
LOx dissolved in a mild organic solvent prior to polymerization may provide for better 
mixing of precursor solution. Alternatively, it may be possible to reduce heterogeneity 
by using different co-solvents altogether. There may exist a “happy medium” between 
aqueous and organic solvents which would maintain adequate enzyme stability while 
also providing for a well mixed precursor solution.  
 5.3.4 Testing system 
 The flow through system described here maintains a flow rate of 4 mL/min 
throughout each flight plan. This allows for autonomous control over lactate 
concentrations exposed to sensing materials, however inherent convective transport is 
also present. Implanted sensors are exposed to diffusion only; convection is not an issue 
in subcutaneous tissue. There may be changes in response to lactate within a flow 
through system caused by convection. Nonetheless, a flow through system was deemed 
necessary to interrogate materials and provides preliminary analysis of tunable sensing 
platform. Currently work is being done to immobilize sensors in highly diffusive 
polymers (e.g. PEG) within the flow cell prior to testing. This would provide diffusion-
only transport to the sensor surface. PEG may reduce diffusion rates, creating another 
variable when analyzing data. Ideally, sensors would be immobilized in a PEG medium 
with lactate and oxygen diffusion characteristics similar to water, thus eliminating 
convection while maintaining comparable diffusion rates. 
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5.4  Multiple analyte detection 
This study highlights the general applicability of the enzyme-oxygen phosphor-
hydrogel platform for analyte sensing as it is a modification of a previous glucose 
sensor. Substitution of analyte-specific enzymes within similar hydrogel materials 
allows for sensitivity over a physiologically relevant lactate range. Again, the high 
degree of control over small molecule diffusion (and thus macro sensor characteristics) 
demonstrates how materials can modulate sensor response over a wide range. This 
platform, in principle, may be used for sensing of other biochemistries such as 
cholesterol, pyruvate, alcohol, thiamine, xanthine, and choline, among others. Future 
studies will investigate alternative-analyte detection towards the goal of multi-analyte 
sensing within a single sensor. 
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